1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality : a prospective study
(
- Contribution to journal › Article
- 2017
-
Mark
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment
(
- Contribution to journal › Article
-
Mark
Genetic determinants of growth hormone and GH-related phenotypes
(
- Contribution to journal › Article
- 2015
-
Mark
Cystatin C Is Not Causally Related to Coronary Artery Disease.
(
- Contribution to journal › Article
-
Mark
Analysis of Low Frequency Protein Truncating Stop-Codon Variants and Fasting Concentration of Growth Hormone.
(
- Contribution to journal › Article
- 2014
-
Mark
Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the malmö diet and cancer study.
(
- Contribution to journal › Article
-
Mark
Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.
(
- Contribution to journal › Article